Stress Related Disorder Clinical Trial
— So-WellOfficial title:
WELL-being Improvement Following a SOphrology Intervention in Hospital Staff
Work stress and psychosocial risks are a major public health problem. Health-care workers (HCW) are particularly at risk. Moreover, non-HCW staff of hospitals can also be at risk, with working environment described as the main risk factor. The University Hospital (CHU) of Clermont-Ferrand is one of the 3 CHUs in France with more than 10% absenteeism, and the first CHU for duration of sick leave. The political orientations favor an approach to improve the quality of life at work. Sophrology is a psychocorporal method used as a therapeutic technique or experienced as a philosophy of life. It is an exclusively verbal and non-tactile method. It combines a set of techniques that will act both on the body and on the mind through breathing exercises, muscle relaxation and mental imagery (or visualization). It allows to find a state of well-being and to activate all physical and psychological potential in order to acquire a better knowledge of oneself. NLP is a set of communication and self-transformation techniques that focuses on reactions rather than the origins of behaviors. NLP associated with sophrology proposes above all to mobilize the resources of the unconscious. Neurolinguistic programming (NLP) strategies are effective in the improvement in mental (anxiety and depression), physical, and social health, both in the general population, in individuals with social/psychological problems or in patients, both in hospital settings or outside hospital. Similary, sophrology also demonstrated some benefits on symptoms of patients. However, these approaches have never been provided in the workplace for the benefits of workers at risk of stress-related disorders. This protocol may permit improvements of stress-related outcomes. Putative short-term benefits: This protocol may incidentally detect cardiac disorders. Any abnormality discovered will not be covered by promotor's insurance (our exploratory study cannot lead to such event) and will be supported by health insurance. In general, the investigators aim to demonstrate the effectiveness of a workplace sophrology / NLP intervention for HCW at risk of stress-related disorders. Stress and well-being will be the target of the intervention, and will be measured both in a subjective (questionnaire) and objective (biomarkers).
Status | Recruiting |
Enrollment | 200 |
Est. completion date | March 2028 |
Est. primary completion date | March 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - worker (HCW or NHCW) from a hospital, - age between 18-65 years, - with a stress greater than 50 on a visual analogue scale (VAS) of stress, - person able to give an informed consent to participate in research and - affiliated with a Social Security scheme Exclusion Criteria: - Psychiatric, cardiovascular (heart failure, arrhythmia, etc.), hepatic (liver failure, etc.), renal (kidney failure, etc.), or endocrinological diseases (diabetes, etc.) judged by the investigator to be incompatible with the study because they may interfere with the measurements - Non-affiliated to a health insurance - Protected persons (minors, pregnant women, breastfeeding women, guardianship, curatorship, deprived of freedoms, safeguard of justice) - Refusal to participate |
Country | Name | City | State |
---|---|---|---|
France | CHU clermont-ferrand | Clermont-Ferrand |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Clermont-Ferrand | Centre National de la Recherche Scientifique, France, University Clermont Auvergne (UCA) |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | heart rate variability (HRV) Description : Abrupt changes in HRV signals will be explored. Time Frame : During 34 hours in five different conditions | HRV will be explored in time and frequency domains using Zephyr™ BioHarness™ BT. | Once per session of sophrology (6 to 8 sessions) during the 2 months intervention | |
Primary | heart rate variability (HRV) Description : Abrupt changes in HRV signals will be explored. Time Frame : During 34 hours in five different conditions | HRV will be explored in time and frequency domains using Zephyr™ BioHarness™ BT. | Once per month during 6 months | |
Secondary | Skin conductance | Measure using Wristband electrodes - Empatica E4 | Once per session of sophrology (6 to 8 sessions) during the 2 months intervention | |
Secondary | Skin conductance | Measure using Wristband electrodes - Empatica E4 | Once per month during 6 months | |
Secondary | Demographics variables | Measure of age, gender, qualification, personal status using a questionnaire | Once at inclusion | |
Secondary | Clinical measurements (height) | Measure of height using a questionnaire | Once at inclusion | |
Secondary | Clinical measurements (weight) | Measure of weight using a questionnaire | Once at inclusion | |
Secondary | Psychology and quality of life (depression) | Measure of depression using HAD 7 items | 5 times : Month 0, Month 1, Month 3, Month 5 and Month 7 | |
Secondary | Psychology and quality of life (anxiety) | Measure of anxiety using HAD 7 items | 5 times : Month 0, Month 1, Month 3, Month 5 and Month 7 | |
Secondary | Psychology and quality of life (burn-out) | Measure of burn-out using Maslach Burn-Out Inventory | 5 times : Month 0, Month 1, Month 3, Month 5 and Month 7 | |
Secondary | Psychology and quality of life (perception of work) | Measure of perception of work using Job Content Questionnaire of Karasek | 5 times : Month 0, Month 1, Month 3, Month 5 and Month 7 | |
Secondary | Psychology and quality of life (alexithymia) | Measure of alexithymia using Toronto Alexithymia Scale (TAS-20) | 5 times : Month 0, Month 1, Month 3, Month 5 and Month 7 | |
Secondary | Psychology and quality of life (VAS stress at home) | Measure of stress at home using visual analog scale of 100 mm ranging from 0 (Minimum) ot 100 (Maximum). Higher scores mean a worse outcome | Once per week during the whole protocol (8 month) | |
Secondary | Psychology and quality of life (VAS stress at work) | Measure of stress at work using visual analog scale of 100 mm ranging from 0 (Minimum) ot 100 (Maximum). Higher scores mean a worse outcome | Once per week during the whole protocol (8 month) | |
Secondary | Psychology and quality of life (VAS fatigue) | Measure of fatigue using visual analog scale of 100 mm ranging from 0 (Minimum) ot 100 (Maximum). Higher scores mean a worse outcome | Once per week during the whole protocol (8 month) | |
Secondary | Psychology and quality of life (VAS sleep quality) | Measure of sleep quality using visual analog scale of 100 mm ranging from 0 (Bad) ot 100 (Excellent). Higher scores mean a better outcome | Once per week during the whole protocol (8 month) | |
Secondary | Psychology and quality of life (VAS anxiety) | Measure of anxiety using visual analog scale of 100 mm ranging from 0 (Minimum) ot 100 (Maximum). Higher scores mean a worse outcome | Once per week during the whole protocol (8 month) | |
Secondary | Psychology and quality of life (VAS mood) | Measure of mood using visual analog scale of 100 mm ranging from 0 (Bad) ot 100 (Excellent). Higher scores mean a better outcome | Once per week during the whole protocol (8 month) | |
Secondary | Psychology and quality of life (VAS family support) | Measure of family support using visual analog scale of 100 mm ranging from 0 (Minimum) ot 100 (Maximum). Higher scores mean a better outcome | Once per week during the whole protocol (8 month) | |
Secondary | Psychology and quality of life (VAS hierarchy support) | Measure of hierarchy support using visual analog scale of 100 mm ranging from 0 (Minimum) ot 100 (Maximum). Higher scores mean a better outcome | Once per week during the whole protocol (8 month) | |
Secondary | Psychology and quality of life (VAS colleagues support) | Measure of colleagues support using visual analog scale of 100 mm ranging from 0 (Minimum) ot 100 (Maximum). Higher scores mean a better outcome | Once per week during the whole protocol (8 month) | |
Secondary | Psychology and quality of life (VAS burnout) | Measure of burnout using visual analog scale of 100 mm ranging from 0 (Minimum) ot 100 (Maximum). Higher scores mean a worse outcome | Once per week during the whole protocol (8 month) | |
Secondary | Psychology and quality of life (VAS job control) | Measure of job control using visual analog scale of 100 mm ranging from 0 (Minimum) ot 100 (Maximum). Higher scores mean a better outcome | Once per week during the whole protocol (8 month) | |
Secondary | Psychology and quality of life (VAS job demand) | Measure of job demand using visual analog scale of 100 mm ranging from 0 (Minimum) ot 100 (Maximum). Higher scores mean a worse outcome | Once per week during the whole protocol (8 month) | |
Secondary | Psychology and quality of life (VAS effort reward imbalance) | Measure of effort reward imbalance using visual analog scale of 100 mm ranging from 0 (Minimum) ot 100 (Maximum). Higher scores mean a better outcome | Once per week during the whole protocol (8 month) | |
Secondary | Lifestyle (coffee, tea and food intakes) | Measure of coffee, tea and food intakes using a questionnaire | Once per week during the whole protocol (8 month) | |
Secondary | Lifestyle (physical activity) | Measure of physical activity using Recent Physical Activity Questionnaire (RAPQ) | Once per session of sophrology (6 to 8 sessions) during the 2 months intervention | |
Secondary | Lifestyle (physical activity) | Measure of physical activity using Recent Physical Activity Questionnaire (RAPQ) | Once per month during 6 months | |
Secondary | Lifestyle (physical activity) | Measure of physical activity using questionnaire | Once per week during the whole protocol (8 month) | |
Secondary | Lifestyle (alcohol, tobacco, cannabis and medication) | Measure of consumption of alcohol, tobacco, cannabis and medication using questionnaire | Once per week during the whole protocol (8 month) | |
Secondary | Sophrology practice (number of sessions per week) | Measure of number of sessions per week using questionnaire | Once per week during the whole protocol (8 month) | |
Secondary | Stress before the last sophrology session | Measure of stress before the last sophrology session using visual analog scale of 100 mm ranging from 0 (Minimum) ot 100 (Maximum). Higher scores mean a worse outcome | Once per session of sophrology (6 to 8 sessions) during the 2 months intervention | |
Secondary | Stress after the last sophrology session | Measure of stress after the last sophrology session using visual analog scale of 100 mm ranging from 0 (Minimum) ot 100 (Maximum). Higher scores mean a worse outcome | Once per session of sophrology (6 to 8 sessions) during the 2 months intervention | |
Secondary | Allostatic load (cortisol) | Measure of cortisol using saliva sampling (and deep-freezing) | Once per session of sophrology (6 to 8 sessions) during the 2 months intervention | |
Secondary | Allostatic load (cortisol) | Measure of cortisol using saliva sampling (and deep-freezing) | Once per month during 6 months | |
Secondary | Allostatic load (DHEAS) | Measure of DHEAS using saliva sampling (and deep-freezing) | Once per session of sophrology (6 to 8 sessions) during the 2 months intervention | |
Secondary | Allostatic load (DHEAS) | Measure of DHEAS using saliva sampling (and deep-freezing) | Once per month during 6 months | |
Secondary | Allostatic load (leptin) | Measure of leptin using saliva sampling (and deep-freezing) | Once per session of sophrology (6 to 8 sessions) during the 2 months intervention | |
Secondary | Allostatic load (leptin) | Measure of leptin using saliva sampling (and deep-freezing) | Once per month during 6 months | |
Secondary | Allostatic load (ghrelin) | Measure of ghrelin using saliva sampling (and deep-freezing) | Once per session of sophrology (6 to 8 sessions) during the 2 months intervention | |
Secondary | Allostatic load (ghrelin) | Measure of ghrelinusing saliva sampling (and deep-freezing) | Once per month during 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04761510 -
Mindfulness-SOS: Stress Reduction for Refugees
|
N/A | |
Completed |
NCT03722095 -
Research on the Effects of Combined Neurostimulation Protocols on Stress
|
N/A | |
Completed |
NCT02972203 -
MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home
|
N/A | |
Completed |
NCT06155162 -
The HuggyPuppy Intervention for War-related Distress
|
N/A | |
Not yet recruiting |
NCT05081830 -
Online Transdiagnostic Intervention for Emotional Disorders and Stress-related Disorders
|
N/A | |
Completed |
NCT04380259 -
Mindfulness-Based Trauma Recovery for Refugees (MBTR-R)
|
Phase 1/Phase 2 | |
Completed |
NCT04611399 -
MIND-VR: Virtual Reality for COVID-19 Operators' Psychological Support
|
N/A | |
Recruiting |
NCT06016530 -
Multi-level Molecular Profiling of Stress Exposure Under Standardized Food Intake: A Clinical Study
|
N/A | |
Recruiting |
NCT05466851 -
An Exploratory Study Examining Biopsychosocial Markers of Anxiety and Depression
|
||
Recruiting |
NCT03623555 -
Applied Social Neuroscience: the Building Resilience Among Women Project
|
||
Enrolling by invitation |
NCT04396600 -
The Professional Peer Resilience Initiative
|
||
Completed |
NCT03308630 -
Immediate Effect of Energy Alignment and Mantra on Stress Related Pain in Adolescents
|
N/A | |
Terminated |
NCT03609450 -
Integrating Mindfulness Into the Patient-Centered Medical Home (Phase 3)
|
N/A | |
Terminated |
NCT04268355 -
MINDFUL-PC for Portuguese Speakers Pilot Study 2020
|
N/A | |
Completed |
NCT05607706 -
Effect of Maternal Odor and Kangaroo Care on Serum Cortisol and Comfort Levels in Preterm Infants: a Randomised Trial
|
N/A | |
Recruiting |
NCT05874856 -
Heart Rate Variability, Physical Activity and Exhaustion in the Inpatient Treatment of Stress-Related Disorders
|
||
Completed |
NCT04278586 -
Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment (R33 Phase)
|
N/A | |
Completed |
NCT03265600 -
Integrating Mindfulness Into the Patient-Centered Medical Home (Phase 2)
|
N/A | |
Recruiting |
NCT05616286 -
Mindfulness-SOS for Refugees
|
N/A | |
Completed |
NCT03798431 -
MINDFUL-OBOT: Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment
|
N/A |